Key regions: China, Europe, Australia, United States, Germany
The Other Pharmaceuticals market in Qatar has been experiencing steady growth in recent years.
Customer preferences: Qatar has a high demand for pharmaceuticals due to its rapidly growing population and high standard of living. The country has a universal healthcare system that provides free or subsidized healthcare to all citizens and residents. As a result, there is a high demand for pharmaceutical products, including Other Pharmaceuticals, in the country.
Trends in the market: The Other Pharmaceuticals market in Qatar has been growing steadily due to the increasing prevalence of chronic diseases such as diabetes and hypertension. Additionally, the government has been investing heavily in healthcare infrastructure and initiatives to improve the quality of healthcare services in the country. This has led to an increased demand for Other Pharmaceuticals products, as well as other healthcare products and services.
Local special circumstances: Qatar is a small country with a high per capita income and a rapidly growing population. The government has been investing heavily in infrastructure and development projects to support the growing population and improve the quality of life for its citizens. Additionally, Qatar has been experiencing a boom in the tourism industry, which has led to an increased demand for healthcare services and pharmaceutical products.
Underlying macroeconomic factors: The Qatar economy is heavily dependent on the oil and gas industry, which has been the main driver of economic growth in the country. However, the government has been working to diversify the economy and reduce its dependence on oil and gas. This has led to increased investment in other sectors, including healthcare. Additionally, the government has been implementing policies to attract foreign investment and promote economic growth, which has led to increased demand for pharmaceutical products and other healthcare services.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
